Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Risperidone E-oxime is a potential impurity found in commercial preparations of risperidone.1,2 Risperidone (Item No. 13629) is a longer-acting benzisoxazole derivative used for treating schizophrenia, and also the psychotic, affective, or behavioral symptoms associated with other disorders.3,4 This second-generation antipsychotic was designed to antagonize both D2 and 5-HT2A receptors.5,6 It has little effect on cholinergic and β-adrenergic receptors but does affect α2-adrenergic and histamine H1 receptors.5,6
WARNING This product is not for human or veterinary use.
1. Identification, isolation and characterization of potential degradation product in risperidone tablets. J. Pharm. Biomed. Anal. 46(1), 165-169 (2008).
2. Development and validation of rapid UHPLC method for determination of risperidone and its impurities in bulk powder and tablets. Int. J. Res. Pharm. Chem. 4(2), 261-266 (2014).
3. Discovering risperidone: The LSD model of psychopathology. Nat. Rev. Drug Discov. 2, 315-320 (2003).
4. Risperidone long-
5. Risperidone for schizophrenia. BMJ 308(6940), 1311-1312 (1994).
6. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14(2), 87-96 (1996).